WeChat Mini Program
Old Version Features

The Effect of Spironolactone on Cardiovascular Function and Markers of Fibrosis in People at Increased Risk of Developing Heart Failure: the Heart ‘omics’ in AGEing (HOMAGE) Randomized Clinical Trial

John G. F. Cleland,Joao Pedro Ferreira,Beatrice Mariottoni,Pierpaolo Pellicori,Joe Cuthbert,Job A. J. Verdonschot,Johannes Petutschnigg,Fozia Z. Ahmed,Franco Cosmi,Hans-Peter Brunner La Rocca,Mamas A. Mamas,Andrew L. Clark,Frank Edelmann,Burkert Pieske,Javed Khan,Ken McDonald,Philippe Rouet,Jan A. Staessen,Blerim Mujaj,Arantxa Gonzalez,Javier Diez,Mark Hazebroek,Stephane Heymans,Roberto Latini,Stephanie Grojean,Anne Pizard,Nicolas Girerd,Patrick Rossignol,Tim J. Collier,Faiez Zannad

European Heart Journal（2020）

Cited 91|Views100
Key words
Spironolactone,Heart failure prevention,Fibrosis,Collagen markers
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined